Finanzwire Finanzwire
Basculer en Français
10592 Companies
224615 Keywords
153330 Articles
118809 Press releases
Headlines Articles Press releases GENSIGHT BIOLOGICS S.A. Remove
  1. Home
  2. Companies
  3. GENSIGHT BIOLOGICS S.A.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/23/2024 at 11:40, 2 years ago

    Crossing thresholds for GENSIGHT BIOLOGICS SA

    Actions Crossing Thresholds GenSight Biologics Armistice Capital Subscription Warrants
  • BRIEF

    published on 05/07/2024 at 19:34, 2 years 1 month ago

    GenSight Biologics Announces Availability of Prospectus for New Shares Listing on Euronext Paris

    Euronext Paris Capital Increase Gene Therapy Prospectus GenSight Biologics
  • PRESS RELEASE

    published on 05/07/2024 at 19:29, 2 years 1 month ago

    Terms of availability of prospectuses

    GenSight Biologics announces availability of listing prospectus for new shares on Euronext Paris. The prospectus approved by AMF includes universal registration document, securities note, and summary
    Euronext Paris New Shares AMF Approval GenSight Biologics Listing Prospectus
    Logo of GENSIGHT BIOLOGICS S.A.
Previous page
1 ... 9 10
Accesswire
  • Published on 06/18/2026 at 00:00, 8 hours 31 minutes ago

    LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide

  • Published on 06/17/2026 at 23:30, 9 hours 1 minute ago

    Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders

  • Published on 06/17/2026 at 22:50, 9 hours 41 minutes ago

    International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results

  • Published on 06/17/2026 at 22:30, 10 hours 1 minute ago

    Innodata Appoints Jayant Chauhan as Chief Financial Officer

  • Published on 06/17/2026 at 16:55, 15 hours 36 minutes ago

    Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

View all ACCESSWIRE
EQS Group
  • Published on 06/18/2026 at 08:05, 25 minutes ago

    Sunparl Releases First ESG Report: Showcasing ZKONG's Smart Retail Innovation and Sustainability Practices

  • Published on 06/18/2026 at 07:30, 1 hour ago

    tonies targets to more than double group revenue by 2030 and announces further international expansion plans at first-ever Capital Markets Day

  • Published on 06/18/2026 at 07:00, 1 hour 30 minutes ago

    Press release: Leonteq concludes regulatory legacy matters

  • Published on 06/18/2026 at 07:00, 1 hour 30 minutes ago

    Successful virtual Annual General Meeting: Ringmetall SE reports from Munich

  • Published on 06/18/2026 at 06:40, 1 hour 50 minutes ago

    APES 2026: 2,000+ Chinese Source Factories, One-Stop Direct Sourcing -Maximizing Buyer Margins

View all EQS
Les Echos
  • Published on 06/18/2026 at 07:00, 1 hour 31 minutes ago

    bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry

  • Published on 06/17/2026 at 17:40, 14 hours 51 minutes ago

    Report on share repurchases from 10 to 16 June 2026

  • Published on 06/17/2026 at 08:45, 23 hours 46 minutes ago

    Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home

  • Published on 06/16/2026 at 11:44, 1 day 20 hours ago

    Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026

  • Published on 06/15/2026 at 23:00, 2 days 9 hours ago

    BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy